Analystreport

CytomX Therapeutics, Inc. (NASDAQ: CTMX) had its price target lowered by analysts at Mizuho from $4.00 to $2.00.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com